1. Home
  2. AMS vs LTRN Comparison

AMS vs LTRN Comparison

Compare AMS & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Shared Hospital Services

AMS

American Shared Hospital Services

N/A

Current Price

$1.08

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

N/A

Current Price

$0.48

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMS
LTRN
Founded
1980
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
10.0M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
AMS
LTRN
Price
$1.08
$0.48
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.50
AVG Volume (30 Days)
8.1K
★ 227.9K
Earning Date
11-12-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.65
EPS
★ N/A
N/A
Revenue
★ $19,714,000.00
N/A
Revenue This Year
$16.37
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 0.81
N/A
52 Week Low
$1.14
$0.45
52 Week High
$2.39
$4.34

Technical Indicators

Market Signals
Indicator
AMS
LTRN
Relative Strength Index (RSI) 31.74 28.73
Support Level N/A N/A
Resistance Level $1.52 $0.84
Average True Range (ATR) 0.06 0.09
MACD -0.00 0.02
Stochastic Oscillator 42.86 7.18

Price Performance

Historical Comparison
AMS
LTRN

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. Company operates in two segments, the medical equipment leasing segment where a contract exists between the hospital and the Company and the direct patient services segment, where a contract exists between the Company facilities and the individual treated at the facility. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates it's key revenue from the domestic market.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: